Roxana Moslehi

From Wikipedia, the free encyclopedia

You have new messages (last change).
Enlarge

Roxana Moslehi, Ph.D. is a leading genetic epidemiologist. Most of her research is dedicated to the study of cancer and cancer precursors. Born in Iran and raised in Canada, she is currently an assistant professor in Epidemiology and Statistics at the State University of New York (SUNY).

Roxana received her B.Sc. with honors, M.Sc. and Ph.D. degrees from the University of British Columbia (UBC) in Vancouver, Canada. Following her Ph.D., she completed a postdoctoral fellowship at the National Institutes of Health (NIH), Division of Cancer Epidemiology and Genetics (DCEG) under the supervision of Dr. Mitchell Gail. While being a postdoctoral fellow at NIH, she also received an adjunct assistant professor position at George Washington University (GWU), where she taught a course with Dr. Paul Levin. Roxana Moslehi is a recipient of multiple awards and honors, including the Award for Excellence in Teaching (UBC), a Biovision Fellowship from Académie des Sciences (France) and two Awards for Research Excellence from the NIH. Working with Steven Narod and J.M. Friedman, she was first to estimate the penetrance of BRCA1 and BRCA2 mutations for breast, ovarian and other cancers in a study of Jewish women with ovarian cancer, now the most studied hereditary cancer predisposing genes in the human genome. She also made significant contributions in the research of various other cancer risk modifying factors, including involvement of NAT genes in colorectal adenomas and infectious pathogen Chlamydia pscittaci in Ocular Non-Hodgkin Lymphomas. In addition to her scientific career she has also done professional runway modeling for fashion shows.

[edit] Refrences

1. BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer[[1]]
2. Rapidly Increasing Incidence of Ocular Non-Hodgkin Lymphoma [[2][3]]
3. Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome.[[4]]
4. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.[[5]]
5. Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome [[6]]

Retrieved from "http://en.wikipedia.org../../../r/o/x/Roxana_Moslehi_a67e.html"